Login to Your Account

Patents: Lifeblood of Biotech or a Cancer to Innovation?

By Anette Breindl

Monday, May 25, 2009
Patent challenges - long a favorite parlor game in the biotech industry, at least for plaintiffs - received a new twist recently with a lawsuit brought by the American Civil Liberties Union and a number of co-plaintiffs against Utah biotechnology company Myriad Genetics and the University of Utah Research Foundation.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription